Wet solid wastes including spent ion exchange resins, evaporator concentrates and sludges require solidification to transform wastes into an acceptable solid, monolithic form for final disposal. The development of the process control program for the solidification of radioactive sludges generated at nuclear power plants has been in progress to provide reasonable assurance that the solidified product will meet the established waste acceptance criteria for solidified waste. A mobile solidification system to produce the solidified waste in the size of a 200 L drum was used, which adopts the in-line mixing method where the waste and binder are mixed and then transferred to the disposable container. To simulate radioactive sludges, non-radioactive sludges are synthesized and the specimens are prepared by using them. The qualification tests on the prepared specimens including the compressive strength test, the thermal cycling test, the irradiation test, the leach test, the immersion test, etc. have been performed to qualify recipes for a range of waste compositions. The results of the tests will be analyzed and discussed.

Glycoproteins isolated from fruit bodies and mycelial cultures of mushrooms exhibit anti-carcinogenic actions in human cancer cells and animal tumor cells by induction of apoptosis. Here, we report that isoflavone-conjugated glycoproteins (designate Gluvone), exhibit strong anti-carcinogenic effects on human breast cancer MCF-7 cells by induction of apoptosis. Gluvone with 9.4 kDa of molecular weight was isolated from submerged-liquid culture of Agaricus blazei mycelia (ABM) in soy flake-containing liquid medium. MCF-7 cells were incubated with various amounts of Gluvone (0~250 μM) for a period of 6 days. Gluvone exhibited anti-proliferative actions in a dose-dependent manner and 62% growth inhibition at 200 μM for 4 days relative to control. Hoechst 33258 staining analysis revealed that Gluvone induced formation of apoptotic bodies. Gluvone was associated with down-regulation of anti-apoptotic Bcl-2 protein expression as well as up-regulation of pro-apoptotic Bax protein expression. Gluvone treatment induced proteolytic activation of caspase-9 and caspase-3 through cytochrome c release from mitochondria to cytosol as well as concomitant degradation of poly (ADP-ribose) polymerase (PARP). In addition, Gluvone induced activation of caspase-8. Taken all together, these results indicate that the anti-proliferative effect of Gluvone is associated with induction of apoptotic cell death through the mitochondrial dysfunction pathway mediated by enhancement of Bax protein expression and suppression of Bcl-2 protein expression.